Cardiology: 150 CME educational programs available now

Acute Coronary Syndromes

Cardiology Fellow X Factor: An ACS Case of Therapeutic Challenges

May 5, 2012 15:48 EDT

Cardiology fellow and X Factor Case winner Dr. Humphrey presents a complex ACS case to Drs. Storey and Wiviott.

Acute Coronary Syndromes

Oral Anticoagulant Therapy in Thromboembolic Disease: The Key Questions

Mar 16, 2012 14:12 EDT

Drs. Bauer, Weitz, Mega, Spyropoulos, and Turpie discuss important clinical questions regarding the care of patients at risk for venous or arterial thromboembolic events

Acute Coronary Syndromes

Personalized PCI: Patient-Centered Care in Practice

Feb 3, 2012 13:22 EST

How to put evidence-based care into practice? Drs. Skelding and Spertus compare 2 complementary systems used in their respective facilities.

Acute Coronary Syndromes

Prevention and Treatment of Venous and Arterial Thromboembolic Disease: Secondary Prevention Following ACS

Feb 1, 2012 14:50 EST

Drs. Ortel, Baker, Eikelboom, Gibson, and Mahaffey review trial data exploring strategies to reduce residual risk in patients status post ACS

Acute Coronary Syndromes

Surveying the Landscape of Antiplatelet Therapy: Optimizing Outcomes in Atherothrombotic Disease

Jan 20, 2012 13:44 EST

Explore recent advances in ACS treatment, with a focus on oral antiplatelet therapies.

Acute Coronary Syndromes

TCT/AHA 2011: Antiplatelet Hot Topics

Dec 7, 2011 15:00 EST

ATLAS-ACS 2, BRIDGE, RAPID GENE, and TRACER are among the trials that Dr. Bhatt interviews Drs. Bonello, Mega, Kastrati, and Kleiman about.

Acute Coronary Syndromes

The Perfect Match: The Appropriate Antiplatelet Strategy for Patients Undergoing Primary PCI

Dec 7, 2011 09:20 EST

Dr. Bates outlines the management of 2 patients from presentation to follow-up including discussion of the 2011 updated PCI guidelines.

Acute Coronary Syndromes

PCI Guidelines 2011: Focus on Antiplatelet Therapies

2 COMMENTS - Nov 30, 2011 16:00 EST

Updated guidelines on use of antiplatelet agents in ACS. Drs. Bates, James, Montelescot, and Storey discuss the winners and losers.

Acute Coronary Syndromes

Balancing CV and GI Risk: Expert Perspectives

1 COMMENT - Nov 29, 2011 16:00 EST

Aspirin increases bleeding; rates are higher with dual therapy. But stopping antiplatelets increases cardiovascular events. Drs. Mehran and Scheiman discuss how to strike the right balance.

Acute Coronary Syndromes

ACS Clinical Trials and Registries Using Antiplatelet Agents: Where Does the Truth Lie?

1 COMMENT - Nov 23, 2011 10:03 EST

Clinical trials and registries. Do we need both? Drs. Lopes and Peterson discuss how to interpret and apply the data in clinical practice.

Acute Coronary Syndromes

Switching Antiplatelet Therapies: Case-Based Guidance on the Use of Platelet Testing

Nov 22, 2011 14:43 EST

Hitting the sweet spot for antiplatelet efficacy. Is platelet reactivity the answer? Drs. Lopes and Becker explore the possibilities.

Acute Coronary Syndromes

Antiplatelets in ACS: Expanding Choices

Oct 21, 2011 16:00 EDT

With the recent approval of a third P2Y₁₂ inhibitor, how should new agents be integrated into practice? Dr. Storey leads a case-based discussion with Drs. Geisler, Mehta, and Wiviott.

Interventional/Surgery

Stable Ischemic Heart Disease: Navigating the Decision to Intervene

Oct 3, 2011 13:44 EDT

When is it appropriate to revascularize patients with stable ischemic heart disease? Dr. King walks through 2 typical cases outlining the data behind his decision-making.

Acute Coronary Syndromes

NSTEMI Guidelines: Are the US and Europe in Harmony?

Sep 29, 2011 11:00 EDT

Dr. White asks Drs. Ohman and Fox about the similarities and differences between the 2 sets of guidelines.

Acute Coronary Syndromes

Antiplatelet Therapy in the Elderly Patient With ACS

Sep 14, 2011 10:50 EDT

Dr. Adam Skolnick reviews the data on how to manage elderly patients with ACS, focusing on antiplatelet and antithrombotic strategies.

Acute Coronary Syndromes

Antiplatelet Strategies in Acute Coronary Syndrome

Aug 30, 2011 14:18 EDT

Antiplatelet options in ACS are expanding across the globe. Dr. Abizaid from Brazil and Dr. Gaxiola from Mexico discuss 2 ACS cases and the data behind their decision-making.

Acute Coronary Syndromes

Acute Coronary Syndrome: Options for Primary and Secondary Prevention

1 COMMENT - Jun 23, 2011 16:00 EDT

Review the pathobiology of ACS, explore the updated guidelines for assessing and managing these patients, and discuss novel pharmacotherapies and issues surrounding platelet function and genetic testing.

Acute Coronary Syndromes

Antiplatelet Therapy for Atherothrombotic Disease: Unmasking the Data

Jun 23, 2011 12:17 EDT

Discuss the efficacy and safety of prescribing antiplatelet agents in patients with atherothrombotic disease.

Acute Coronary Syndromes

Antiplatelet Resistance: Does It Matter?

3 COMMENTS - Jun 22, 2011 15:32 EDT

GRAVITAS and the early cessation of TRIGGER-PCI left many wondering if testing antiplatelet response is worth it. Drs. ten Berg and Collet discuss the practical application of all the data.

Acute Coronary Syndromes

Defining the Future of Oral Anticoagulant Therapy: Across the Spectrum of Thromboembolic Disease

May 25, 2011 10:38 EDT

Drs. Becker and Weitz lead a discussion with Drs. Agnelli, Ezekowitz, Heit, and Mahaffey on the envisioned improvements in care of patients with thromboembolic disease

Acute Coronary Syndromes

Dispelling Myths and Discussing Unresolved Issues in Transradial vs Transfemoral Access in PCI

11 COMMENTS - Oct 18, 2010 10:46 EDT

Join Drs. Rao, Popma, Kandzari, and Kern as they discuss barriers to developing a radial-first strategy.

Acute Coronary Syndromes

Proton Pump Inhibitors and Dual Antiplatelet Therapy: Myths and Reality

3 COMMENTS - Jul 30, 2010 10:53 EDT

Do PPIs affect thienopyridine efficacy? The data so far are conflicting. Dr. Gilles Montalescot provides insights from a new meta-analysis.

Acute Coronary Syndromes

Antiplatelet Therapy: Point-of-Care Testing 101

1 COMMENT - Jul 21, 2010 09:53 EDT

Drs. Storey, Kereiakes, and Montalescot discuss the use of point-of-care testing to assess antiplatelet responsiveness, including strategies for treating poor responders.

Acute Coronary Syndromes

Minimizing the Risk for Stent Thrombosis

4 COMMENTS - Jul 8, 2010 13:37 EDT

Dr. Gershlick quizzes Dr. Collet regarding his stent-thrombosis prevention strategies and his thoughts on trials such as GRAVITAS and DAPT.

Acute Coronary Syndromes

Tailoring Oral Antiplatelet Therapy in ACS Patients Undergoing PCI

Jul 8, 2010 12:57 EDT

POPULAR PI Dr. ten Berg discusses the practicalities of using genetics and platelet-response assays to optimize antiplatelet therapy.